Schiavi & Co LLC Invests $385,000 in Agilent Technologies, Inc. (NYSE:A)

Schiavi & Co LLC purchased a new stake in Agilent Technologies, Inc. (NYSE:A) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 2,866 shares of the medical research company’s stock, valued at approximately $385,000. Agilent Technologies makes up approximately 0.2% of Schiavi & Co LLC’s portfolio, making the stock its 18th largest holding.

A number of other hedge funds have also bought and sold shares of the business. Norges Bank bought a new stake in shares of Agilent Technologies during the 4th quarter valued at $456,963,000. Madison Investment Advisors LLC acquired a new position in Agilent Technologies in the fourth quarter valued at about $94,051,000. Raymond James Financial Inc. acquired a new stake in Agilent Technologies during the fourth quarter worth about $48,172,000. Van ECK Associates Corp grew its stake in Agilent Technologies by 8.7% during the fourth quarter. Van ECK Associates Corp now owns 3,235,263 shares of the medical research company’s stock worth $434,625,000 after buying an additional 258,358 shares in the last quarter. Finally, Proficio Capital Partners LLC bought a new position in Agilent Technologies in the 4th quarter valued at about $26,066,000.

Wall Street Analyst Weigh In

Several research firms recently issued reports on A. Bank of America reduced their price target on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research report on Friday, December 13th. StockNews.com raised Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. Barclays lowered their price target on Agilent Technologies from $138.00 to $115.00 and set an “equal weight” rating for the company in a report on Thursday. Citigroup raised their price objective on Agilent Technologies to $165.00 and gave the company a “buy” rating in a research note on Thursday, December 19th. Finally, Robert W. Baird lowered their target price on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a research note on Thursday, February 27th. Seven equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $146.25.

Agilent Technologies Trading Down 6.8 %

Shares of NYSE A opened at $99.77 on Friday. The firm has a 50 day moving average price of $124.64 and a two-hundred day moving average price of $134.18. The stock has a market cap of $28.44 billion, a P/E ratio of 22.93, a price-to-earnings-growth ratio of 3.00 and a beta of 1.19. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $155.35. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. The business had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. As a group, equities analysts forecast that Agilent Technologies, Inc. will post 5.57 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be paid a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.99%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio is currently 22.76%.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, Director Daniel K. Podolsky sold 1,819 shares of the company’s stock in a transaction on Monday, March 31st. The shares were sold at an average price of $116.46, for a total transaction of $211,840.74. Following the sale, the director now owns 35,737 shares of the company’s stock, valued at approximately $4,161,931.02. This represents a 4.84 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, VP Rodney Gonsalves sold 1,908 shares of the business’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the completion of the transaction, the vice president now directly owns 21,786 shares in the company, valued at $2,657,456.28. This represents a 8.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 5,638 shares of company stock valued at $731,229.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.